Phytoestrogens and diseases of the prostate gland

Bailliere's Clinical Endocrinology and Metabolism

Volumn 12, Issue 4, 1998, Pages 625-647

  Griffiths, K ^a   Denis, L ^a   Turkes, A ^a   Morton, M S ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

Cancer; Isoflavonoids; Lignans; Prostate

Indexed keywords

ANDROGEN; EPIDERMAL GROWTH FACTOR; ESTROGEN; FIBROBLAST GROWTH FACTOR; FLAVONOID; GENISTEIN; GLUCOCORTICOID; ISOFLAVONOID; KERATINOCYTE GROWTH FACTOR; LIGNAN; PHYTOESTROGEN; SOMATOMEDIN B; SOMATOMEDIN C; STEROID HORMONE;

BLADDER NECK STENOSIS; CANCER MORTALITY; CELL PROLIFERATION; DIET; ENVIRONMENTAL FACTOR; GEOGRAPHIC DISTRIBUTION; HUMAN; LUNG CANCER; MALE; PROSTATE CANCER; PROSTATE HYPERTROPHY; RACE DIFFERENCE; REVIEW; SKIN CANCER; SOYBEAN; UNITED STATES;

GLYCINE MAX;

EID: 0032460067     PISSN: 0950351X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0950-351X(98)80008-6     Document Type: Article

References (107)

1. Adlercreutz H. Fotsis T. Bannwart C. Determination of urinary lignans and phytoestrogen metabolites, potential antiestrogens and anticarcinogens, in urine of women on various habitual diets Journal of Steroid Biochemistry 25 1986 791 797
2. Adlercreutz H. Fotsis T. Bannwart C. Urinary oestrogen profile determination in young Finnish vegetarian and omnivorous women Journal of Steroid Biochemistry 24 1986 289 296
3. Adlercreutz H. Hockerstedt K. Bannwart C. Effect of dietary components, including lignans and phytoestrogens on enterohepatic circulation and liver metabolism of estrogens and on sex hormone binding globulin (SHBG) Journal of Steroid Biochemistry 27 1987 1135 1144
4. Adlercreutz H. Bannwart C. Wahala K. Inhibition of human aromatase by mammalian lignans and isoflavonoid phytoestrogens Journal of Steroid Biochemistry and Molecular Biology 44 1993 147 153
5. Akiyama T. Ishida J. Nakagawa S. Genistein, a specific inhibitor of tyrosine-specific protein kinases Journal of Biological Chemistry 262 1987 5592 5595
6. Axelson M. Sjovall J. Gustafsson B.E. Setchell K.D.R. A dietary source of the non-steroidal oestrogen equol in man and animals Journal of Endocrinology 102 1984 49 56
7. Baba S. Epidemiology of prostate cancer: analysis of countries of high and low incidence Jacobi G.H. Hohenfeliner R. International Perspectives in Urology, vol. 3, Prostate Cancer 1982 Williams & Wilkins Baltimore 11 28
8. Bagshaw M.A. Cox R.S. Ray G.R. Status of radiation treatment of prostate cancer at Stanford University NCI Monographs 7 1988 47 60
9. Barry M.J. Boyle P. Fourcroy J. Epidemiology and natural history of BPH Cockett A.T.K. Khoury S. Aso Y. The 3rd International Consultation on Benign Prostatic Hyperplasia 1996 SCI Paris 21 36
10. Beato M. Herrlich P. Schutz G. Steroid hormone receptors: many actors in search of a plot Cell 83 1995 851 857
11. Belanger A. Locong A. Noel C. Influence of diet on plasma steroids and sex hormone-binding globulin levels in adult men Journal of Steroid Biochemistry 32 1989 829 833
12. Berry S.J. Coffey D.S. Walsh P.C. Ewing L.L. The development of human benign prostatic hyperplasia with age Journal of Urology 132 1984 474 479
13. Bishop J.M. Cellular oncogenes and retroviruses Annual Review of Biochemistry 52 1985 301 354
14. Bonkhoff H. Remberger K. Differentiation pathways and histogenetic aspects of normal and abnormal prostatic growth: a stem cell model Prostate 28 1996 98 106
15. Bostwick D.G. Brawer M.K. Prostatic intra-epithelial neoplasia and early invasion in prostate cancer Cancer 59 1987 788 794
16. Boyle P. The evolution of an epidemic of unknown origin Denis L. Prostate Cancer 2000 European School of Oncology Monographs 1994 Springer-Verlag New York 5 11
17. Boyle P. Napalkov P. Barry M.J. Epidemiology and natural history of prostate cancer Murphy G. Denis L. Chatelain C. First International Consultation on Prostate Cancer 1997 SCI Paris 1 29
18. Boyle P. Barry M.J. Farah R. Epidemiology and natural history of benign prostatic hyperplasia Denis L.J. Cockett A.T.K. Aso Y. The 4th International Consultation on BPH 1998 SCI Paris 25 59
19. Bruchovsky N. Lesser B. VanDoorn E. Craven S. Hormonal effects on cell proliferation in rat prostate Vitamins and Hormones 33 1975 61 102
20. Chodak G.W. Krane D.M. Puy L.A. Nuclear localization of androgen receptor in heterogeneous samples of normal, hyperplastic and neoplastic human prostate Journal of Urology 147 1992 798 803
21. Chung L.W.K. Cunha G.R. Stromal-epithelial interactions. II: Regulation of prostatic growth by embryonic urogenital sinus mesenchyme Prostate 4 1983 503 511
22. Constantinou A. Mehta R. Runyan C. Flavonoids as DNA topoisomerase antagonists and poisons: structure-activity relationships Journal of Natural Products 58 1995 217 225
23. Cummings J. Smyth J.F. DNA topoisomerase I and II as targets for rational design of new anticancer drugs Annals of Oncology 4 1993 533 543
24. Cunha G.R. Chung L.W.K. Shannon J.M. Hormone-induced morphogenesis and growth: role of mesenchymal-epithelial interactions Recent Progress in Hormone Research 39 1983 559 595
25. Denis L.J. Controversies in the management of localised and metastatic prostate cancer European Journal of Cancer 27 1991 333 341
26. (supplement) Denis L.J. To screen or not to screen? Prostate 4 1992 63 70
27. Denis L. Prostate cancer: primary hormonal treatment Cancer 71 1993 1050 1058
28. Evans B.A.J. Griffiths K. Morton M. Inhibition of 5α-reductase and 17β-hydroxysteroid dehydrogenase in genital skin fibroblasts by dietary lignans and isoflavonoids Journal of Endocrinology 147 1995 295 302
29. (supplement) Finlay E.M.H. Wilson D.W. Adlercreutz H. Griffiths K. The identification and measurement of ‘phyto-oestrogens’ in human saliva, plasma, breast aspirate or cyst fluid, and prostatic fluid using gas chromatography-mass spectrometry Journal of Endocrinology 129 1991 49
30. Folkman J. Toward an understanding of angiogenesis: search and discovery Perspectives in Biology and Medicine 29 1985 10 36
31. Folkman J. Watson K. Ingber D. Hanahan D. Induction of angiogenesis during the transition from hyperplasia to neoplasia Nature 339 1989 58 61
32. Fotsis T. Pepper M. Adlercreutz H. Genistein, a dietary-derived inhibitor of in vitro angiogenesis Proceedings of the National Academy of Sciences of the USA 90 1993 2690 2694
33. Franks L.M. Riddle P.N. Carbonell A.W. Gey G.O. A comparative study of the ultrastructure and lack of growth capacity of adult human prostate epithelium mechanically separated from its stroma Journal ofPathology 100 1970 113 119
34. Garraway W.M. Collins G.N. Lee R.J. High prevalence of benign prostatic hypertrophy in the community Lancet 338 1991 469 471
35. Geller J. Sionit L. Partido C. Genistein inhibits the growth of human-patient BPH and prostate cancer in histoculture Prostate 34 1998 75 79
36. Glynne R.J. Campion E.W. Bouchard G.R. Silbert J.E. The development of benign prostatic hyperplasia among volunteers in the normative aging study American Journal of Epidemiology 121 1985 78 90
37. Griffiths K. Morton M.S. Nicholson R.I. Androgens, androgen receptors, antiandrogens and the treatment of prostate cancer European Urology 32 supplement 3 1997 24 40
38. Griffiths K. Akaza H. Eaton C.L. Regulation of prostate growth Cockett A.T.K. Khoury S. Aso Y. The 2nd International Consultation on Benign Prostatic Hyper plasia 1993 SCI Paris 49 75
39. Griffiths K. Coffey D. Cockett A.T.K. The regulation of prostatic growth Cockett A.T.K. Khoury S. Aso Y. The 3rd International Consultation on Benign Prostatic Hyperplasia 1996 SCI Paris 73 115
40. Griffiths K. Adlercreutz H. Boyle P. Nutrition and Cancer 1996 Isis Medical Media Oxford
41. Griffiths K. Cockett A.T.K. Coffey D.S. Regulation of prostate growth Denis L. Griffiths K. Khoury S. 4th International Consultation on BPH 1998 SCI Paris 83 128
42. Griffiths K. Denis L. Turkes A. Morton M.S. Possible relationship between dietary factors and pathogenesis of prostate cancer International Journal of Urology 5 1998 195 213
43. Guess H.A. Epidemiology and natural history of benign prostatic hyperplasia Urology Clinics of North America 22 1995 247 261
44. Haenszel W. Kurihara M. Studies of Japanese migrants. I: Mortality from cancer and other diseases among Japanese in the United States Journal of the National Cancer Institute 40 1968 43 68
45. Harper M.E. Glynne-Jones E. Goddard L. Vascular endothelial growth factor (VEGF) expression in prostatic tumours and its relationship to neuroendocrine cells British Journal of Cancer 74 1996 910 916
46. Holtgrewe H.L. Ackerman R. Bay-Nielsen H. The economics of BPH Cockett A.T.K. Khoury S. Aso Y. The 3rd International Consultation on Benign Prostatic Hyperplasia 1996 SCI Paris 53 70
47. Huggins C. Hodges C.V. Studies on prostatic cancer. I: The effect of castration, of estrogen and of androgen injection on serum phosphatases in metastatic carcinoma of the prostate Cancer Research 1 1941 293 297
48. Huggins C. Stevens R.E. Hodges C.V. Studies on prostatic cancer Archives of Surgery 43 1941 209 223
49. Hunter T. Cooper J.A. Protein tyrosine kinases Annual Review of Biochemistry 54 1985 897 930
50. Imperato-McGinley J. Guerro L. Gautier T. Peterson R.E. Steroid 51-reductase deficiency in man: an inherited form of male pseudohermaphroditism Science 186 1974 1213 1215
51. (supplement) Isaacs J.T. Coffey D.S. Etiology and disease process of benign prostatic hyperplasia Prostate 2 1989 33 50
52. Isaacs J.T. Cussenot O. Jankevicius F. Growth regulation of normal and malignant prostatic cells Murphy G. Denis L. Chatelain C. First International Consultation on Prostate Cancer 1997 SCI Paris 31 81
53. Kastendieck H. Correlations between atypical primary hyperplasia and carcinoma of the prostate: a histological study of 180 prostatectomies Pathology Research and Practice 169 1980 366 387
54. Kenyon G.L. Garcia G.A. Design of kinase inhibitors Medical Research Review 7 1987 389 416
55. Kiguchi K. Glesne D. Chubb C.H. Differential induction of apoptosis in human breast cells by okadaic acid and related inhibitors of protein phosphatases 1 and 2A Cell Growth and Differentiation 5 1994 995 1004
56. (supplement) Kovi J. Mostofi F.K. Atypical hyperplasia of prostate Urology 34 1989 23 27
57. Krieg M. Nass R. Tun S. Effect of aging on endogenous level of 5α-dihydrotestosterone, testosterone, estradiol, and estrone in epithelium and stroma of normal and hyperplastic human prostate (BPH) Journal of Clinical Endocrinology and Metabolism 77 1993 375 381
58. Kuiper G.G. Carlson B. Grandien K. Comparison of the ligand binding specificity of transcript tissue distribution of estrogen receptors alpha and beta Endocrinology 138 1997 863 870
59. Kuo M.L. Lin J.K. Huang T.S. Yang N.C. Reversion of the transformed phenotypes of v-H-ras NIH3T3 cells by flavonoids through attenuating the content of phosphotyrosine Cancer Letters 87 1994 91 97
60. Lee C. Sensibar J.A. Dudek S.M. Prostatic ductal system in rats: regional variation in morphological and functional activities Biological Reproduction 43 1990 1079 1086
61. Lytton B. Emery J. Harward B.M. The incidence of benign prostatic obstruction Journal of Urology 99 1968 639 645
62. McCabe M.J. Jr. Orrenius S. Genistein induces apoptosis in immature human thymocytes by inhibiting topoisomerase-II Biochemical and Biophysical Research Communications 194 1993 944 950
63. McNeal J.E. The zonal anatomy of prostate Prostate 2 1981 35 49
64. McNeal J.E. Bostwick D.G. Intraductal dysplasia: a premalignant lesion of the prostate Human Pathology 17 1986 54 71
65. McNeal J.E. Bostwick D.G. Kindrachuk R.A. Patterns of progression in prostate cancer Lancet i 1986 60 63
66. Mangelsdorf D.J. Evans R.M. The RXR heterodimers and orphan receptors Cell 83 1995 841 850
67. Mangiapane H. Thomson J. Salter A. The inhibition of the oxidation of low density lipoprotein by (+)-catechin, a naturally occurring flavonoid Biochemical Pharmacology 43 1992 445 450
68. Martin P.M. Horwitz K.B. Ryan D.S. McGuire W.L. Phytoestrogen interaction with estrogen receptors in human breast cancer cells Endocrinology 103 1978 1860 1867
69. Matsukawa Y. Marui N. Sakai T. Genistein arrests cell cycle progression at G2-M Cancer Research 53 1993 1328 1331
70. Messina M.J. Persky V. Setchell K.D.R. Barnes S. Soy intake and cancer risk: a review of the in vitro and in vivo data Nutrition and Cancer 21 1994 113 130
71. Miki T. Bottaro D.P. Fleming T.P. Determination of ligand-binding specificity by alternate splicing: two distinct growth factor receptors encoded by a single gene Proceedings of the National Academy of Sciences of the USA 89 1992 246 250
72. Miksicek R.J. Commonly occuring plant flavonoids have estrogenic activity Molecular Pharmacology 44 1993 37 43
73. Miller J.G. Diagnosis of stage A prostate cancer in People's Republic of China Coffey D.S. Resnick M.I. Dorr F.A. Karr J.P. A Multidisciplinary Analysis of Controversies in the Management of Prostatic Cancer 1988 Plenum Press New York 17 24
74. Morton M.S. Griffiths K. Blacklock N. The preventive role of diet in prostatic disease British Journal of Urology 77 1996 481 493
75. (submitted for publication) Morton M.S. Evans B.A.J. Arisaka O. Concentrations of isoflavonoids in plasma of Japanese and British subjects, both male and female Lancet 1998
76. Morton R.A. Steiner M.S. Walsh P.C. Cancer control following anatomical radical prostatectomy: an interim report Journal of Urology 145 1991 1197 1200
77. Oota K. Misu Y. A study on latent carcinoma of the prostate in Japanese Gann 49 1958 283 293
78. IARC Scientific Publication No. 120 Parkin D.M. Muir C.S. Whelan S. Cancer Incidence in Five Continents vol. VI 1992 International Agency for Research on Cancer Lyon
79. Peehl D.M. Wong S.T. Rubin J.S. KGF and EGF differentially regulate the phenotype of prostatic epithelial cells Growth Regulation 6 1996 22 31
80. Peterson G. Barnes S. Genistein and biochanin A inhibit the growth of human prostate cancer cells but not epidermal growth factor receptor tyrosine autophosphorylation Prostate 22 1993 335 345
81. Price K.R. Fenwick G.R. Naturally occurring oestrogens in food—a review Food Additives and Contaminants 2 1985 73 106
82. Rice-Evans C.A. Miller N.J. Bolwell P.G. The relative antioxidant activities of plant-derived polyphenolic flavonoids Free Radical Research 22 1995 375 383
83. Rittmaster R.S. Finasteride New England Journal of Medicine 330 1994 120 125
84. Ross R.K. Bernstein L. Lobo R.A. 5-alpha-reductase activity and risk of prostate cancer among Japanese and US white and black males Lancet 339 1992 887 889
85. Saatcioglu F. Claret F.X. Karin M. Negative transcriptional regulation by nuclear receptors Seminars in Cancer Biology 5 1994 347 359
86. Sakr W.A. High grade prostatic intraepithelial neoplasia: additional links to a potentially more aggressive prostate cancer? Journal of the National Cancer Institute 90 1998 486 487
87. Santibanez J.F. Navarro A. Martinet J. Genistein inhibits proliferation and in vitro invasive potential of human prostatic cancer cell lines Anticancer Research 17 1997 1199 1204
88. Schlessinger J. Schreiber A.B. Levi A. Regulation of cell proliferation by epidermal growth factor Critical Reviews in Biochemistry 14 1983 93 111
89. Scholar E.M. Toews M.L. Inhibition of invasion of murine mammary carcinoma cells by the tyrosine kinase inhibitor genistein Cancer Letters 87 1994 159 162
90. Schroeder F.H. Boyle P. Screening for prostate cancer: necessary or nonsense? European Journal of Cancer 29A 1993 656 661
91. Schroeder F.H. Albrecht W. Auvinen A. Screening and early detection of prostate cancer Murphy G.P. Denis L. Griffiths K. The 1st International Consultation on Prostatic Cancer 1996 SCI Paris 179 188
92. Sensibar J.A. Griswold M.D. Sylvester S.R. Prostatic ductal system in rats: regional variation in localisation of an androgen-repressed gene product, sulfated glycoprotein-2 Endocrinology 128 1991 2091 2102
93. Shemshedini L. Knauthe R. Sassone-Corsi P. Cell specific inhibitory and stimulatory effects of fos and jun on transcription activation by nuclear receptors EMBO Journal 10 1991 3839 3849
94. Shimizu H. Ropp R.K. Bernstein L. Cancers of the breast and prostate among Japanese and white immigrants in Los Angeles County British Journal of Cancer 63 1991 963 966
95. Sugimura Y. Foster B.A. Hom Y.K. Keratinocyte growth factor (KGF) can replace tesosterone in the ductal branching morphogenesis of the rat ventral prostate International Journal of Developnaental Biology 40 1996 941 951
96. Tiisala S. Majuri M.L. Carpen O. Renkonen R. Genistein enhances the ICAM-mediated adhesion by inducing the expression of ICAM-1 and its counter receptors Biochemical and Biophysical Research Communications 203 1994 443 449
97. Truss M. Beato M. Steroid hormone receptors: interaction with deoxyribonucleic acid and transcription factors Endocrine Reviews 14 1993 459 479
98. Verdeal K. Brown R.R. Richardson T. Ryan D.S. Affinity of phytoestrogens for estradiol-binding proteins and effect of coumestrol on growth of 7,12-dimethylbenz(a) anthracene-induced rat mammarytumors Journal of the National Cancer Institute 64 1980 285 290
99. Vermeulen A. Metabolic effects of obesity in men Verhandelingen-Koninklijke Academie Voor Geneeskunde Van Belgie 55 1993 393 397
100. Vermeulen A. Deslypere J.P. Meirleir K. A new look to the andropause: altered function of the gonadotrophs Journal of Steroid Biochemistry 32 1989 163 165
101. Vermeulen A. van Camp A. Mattelaer J. De Sy W. Hormonal factors related to abnormal growth of the prostate Coffey D.S. Isaacs J.T. Prostate Cancer UICC Technical Workshop Series vol. 48 1979 UICC Geneva 81 92
102. Weidner M. Semple J.P. Welch W.R. Folkman J. Tumour angiogenesis and metaplasia-correlation in invasive breast cancer New England Journal of Medicine 324 1991 1 8
103. World Health Organisation Trends in prostate cancer 1980–1988 WHO Weekly Epidemiological Record 67 1992 281 288
104. Yamamoto K.R. Steroid receptor regulated transcription of specific genes and gene networks Annual Review of Genetics 19 1985 209 252
105. Yan G. Fukabori Y. Nikoloropolous S. Heparin-binding keratinocyte growth factor is a candidate stromal to epithelial cell andromedin Molecular Endocrinology 6 1992 2123 2128
106. Zaridze D.G. Boyle P. Cancer of the prostate: epidemiology and aetiology British Journal of Urology 59 1987 493 502
107. Zaridze D.G. Boyle P. Smans M. International trends in prostatic cancer International Journal of Cancer 33 1984 223 230